Finance

Beta
Ask
Lists
PRU:NYSE
Prudential Financial Inc
$108.93
+2.25%
(+2.40) 1D
Jun 22, 12:53:33 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRU...
Open
$107.07
High
$109.35
Low
$106.19
Mkt. cap
37.80B
Avg. vol.
1.88M
Volume
515.04K
Dividend
5.14%
Quarterly dividend
$1.40
Ex-dividend date
May 26, 2026
P/E ratio
11.19
52-wk high
$119.76
52-wk low
$91.89
EPS
$9.73
Beta
0.86
Shares outstanding
347.00M
No. of employees
37K
Open
$107.07
High
$109.35
Low
$106.19
Mkt. cap
37.80B
Avg. vol.
1.88M
Volume
515.04K
Dividend
5.14%
Quarterly dividend
$1.40
Ex-dividend date
May 26, 2026
P/E ratio
11.19
52-wk high
$119.76
52-wk low
$91.89
EPS
$9.73
Beta
0.86
Shares outstanding
347.00M
No. of employees
37K
Analyst outlook
Analyst Ratings
Based on 14 analysts giving stock ratings to PRU in the past 3 months
Sell
Buy
0
Hold
10
Sell
4
12 month forecast
Based on 14 Wall Street analysts offering 12 month price targets for PRU in the last 3 months.
Highest
Current $108.93
$117.00 (+7.41%)
Average
$99.64 (-8.53%)
Lowest
$87.00 (-20.13%)
News stories
From sources across the web
Profile
Prudential Financial, Inc. is an American financial services company whose subsidiaries provide insurance, retirement planning, investment management, and other products and services to both retail and institutional customers throughout the United States and in over 40 other countries. In 2019, Prudential was the largest insurance provider in the United States with $815.1 billion in total assets. The company is included in the Fortune Global 500 and Fortune 500 rankings. Wikipedia
About Prudential Financial Inc
CEOAndrew F. Sullivan
Employees36.6K
Founded1875
HeadquartersNewark, New Jersey, United States
SectorInsurance
Websiteprudential.com
Analyst Ratings
Based on 14 analysts giving stock ratings to PRU in the past 3 months
Sell
Buy
0
Hold
10
Sell
4
12 month forecast
Based on 14 Wall Street analysts offering 12 month price targets for PRU in the last 3 months.
Highest
Current $108.93
$117.00 (+7.41%)
Average
$99.64 (-8.53%)
Lowest
$87.00 (-20.13%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Unknown Analyst
Raymond James
Hold
Maintained
-
-
06/18/2026
Kevin Heal
Argus Research
Hold
Downgraded
$103.72
-4.8%
06/08/2026
Bob Huang
Morgan Stanley
Sell
Maintained
$92.00
-15.5%
05/21/2026
Ryan Krueger
KBW
Hold
Maintained
$106.00
-2.7%
05/13/2026
Wesley Carmichael
Wells Fargo
Sell
Maintained
$100.00
-8.2%
05/12/2026
John Barnidge
Piper Sandler
Hold
Reiterated
$105.00
-3.6%
05/11/2026
Yaron Kinar
Mizuho Securities
Hold
Maintained
$101.00
-7.3%
05/07/2026
Michael Ward CFA
UBS
Hold
Maintained
$92.00
-15.5%
05/06/2026
Jack Matten
BMO Capital
Sell
Reiterated
$87.00
-20.1%
05/06/2026
Paul Newsome
Piper Sandler
Hold
Maintained
$99.00
-9.1%
05/06/2026
Alex Scott
Barclays
Sell
Maintained
$90.00
-17.4%
05/06/2026
Pablo Singzon
J.P. Morgan
Hold
Maintained
$117.00
+7.4%
05/04/2026
Suneet Kamath
Jefferies
Hold
Downgraded
$98.00
-10%
04/22/2026
Joshua Shanker
Bank of America Securities
Hold
Maintained
$104.00
-4.5%
04/14/2026
Unknown Analyst
Wolfe Research
Hold
Maintained
-
-
04/06/2026
Andrew Kligerman
TD Cowen
Hold
Reiterated
$105.00
-3.6%
03/05/2026
Jimmy Bhullar
J.P. Morgan
Hold
Reiterated
-
-
03/05/2026
Thomas Gallagher
Evercore ISI
Hold
Maintained
$110.00
+1%
02/04/2026
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$3.61 / $3.07
+17.62%beat
Revenue / Est. (USD)
15.53B / 14.19B
+9.40%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
13.73B
17.88B
16.16B
15.53B
Cost of goods sold
9.81B
12.83B
11.00B
11.32B
Cost of revenue
9.81B
12.83B
11.00B
11.32B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.18B
3.28B
3.48B
3.47B
Operating expense
3.18B
3.28B
3.48B
3.47B
Total operating expenses
12.99B
16.11B
14.48B
14.79B
Operating income
740.00M
1.77B
1.68B
733.00M
Other non operating income
-
-
-
-
EBT including unusual items
761.00M
1.86B
1.21B
735.00M
EBT excluding unusual items
761.00M
1.86B
1.21B
735.00M
Income tax expense
195.00M
382.00M
269.00M
129.00M
Effective tax rate
25.62%
20.48%
22.23%
17.55%
Other operating expenses
-
-
-
-
Net income
533.00M
1.43B
905.00M
597.00M
Net profit margin
3.88%
8.00%
5.60%
3.85%
Earnings per share
3.58
4.26
3.30
3.61
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
1.22B
1.83B
1.71B
876.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer